Literature DB >> 1612643

Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.

C Cambiaggi1, M T Scupoli, T Cestari, F Gerosa, G Carra, G Tridente, R S Accolla.   

Abstract

In this study we describe the generation and characterization of interspecies somatic cell hybrids between human activated mature T cells and mouse BW5147 thymoma cells. A preferential segregation of human chromosomes was observed in the hybrids. Phenotypic analysis of two hybrids and their clones demonstrated coexpression of CD4 and CD69 antigens in the same cells. Segregation analysis of an informative family of hybrids followed by molecular and karyotype studies clearly demonstrated that the locus encoding CD69 antigen mapped to human chromosome 12. Although the expression of CD69 antigen is an early event after T-lymphocyte activation and rapidly declines in absence of exogenous stimuli, in the hybrids described in this study the expression was constitutive, similarly to what was previously found in early thymocyte precursors and mature thymocytes. In this respect it was important to note that the behavior of the hybrids in culture strongly suggested a dominant influence of the thymus-derived mouse tumor cell genome in controlling the constitutive expression of human CD69. These hybrids may thus provide a system to study the genetic and molecular mechanisms controlling the expression and function of this activation antigen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612643     DOI: 10.1007/bf00215288

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  22 in total

1.  Structural analysis of the CD69 early activation antigen by two monoclonal antibodies directed to different epitopes.

Authors:  F Gerosa; M Tommasi; M Scardoni; R S Accolla; T Pozzan; M Libonati; G Tridente; G Carra
Journal:  Mol Immunol       Date:  1991 Jan-Feb       Impact factor: 4.407

2.  Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls.

Authors:  S Sartoris; M T Scupoli; L Scarpellino; F Paiola; M Jotterand-Bellomo; G Tridente; R S Accolla
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

Review 3.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.

Authors:  K S Ullman; J P Northrop; C L Verweij; G R Crabtree
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell precursors.

Authors:  A Risso; M E Cosulich; A Rubartelli; M R Mazza; A Bargellesi
Journal:  Eur J Immunol       Date:  1989-02       Impact factor: 5.532

5.  T cell activation via Leu-23 (CD69).

Authors:  R Testi; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

6.  Expression of early activation antigen (CD69) during human thymic development.

Authors:  L K Jung; B F Haynes; S Nakamura; S Pahwa; S M Fu
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

7.  CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression.

Authors:  A Risso; D Smilovich; M C Capra; I Baldissarro; G Yan; A Bargellesi; M E Cosulich
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

8.  The 28-kDa/32-kDa activation antigen EA 1. Further characterization and signal requirements for its expression.

Authors:  J M Bjorndahl; S Nakamura; T Hara; L K Jung; S M Fu
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

9.  CD69 is expressed on platelets and mediates platelet activation and aggregation.

Authors:  R Testi; F Pulcinelli; L Frati; P P Gazzaniga; A Santoni
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Activation of natural killer cells via the p75 interleukin 2 receptor.

Authors:  J H Phillips; T Takeshita; K Sugamura; L L Lanier
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  16 in total

1.  Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen.

Authors:  M T Scupoli; S Sartoris; M Nicolis; T Cestari; C Cambiaggi; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

2.  Identification of natural killer cell receptor clusters in the platypus genome reveals an expansion of C-type lectin genes.

Authors:  Emily S W Wong; Claire E Sanderson; Janine E Deakin; Camilla M Whittington; Anthony T Papenfuss; Katherine Belov
Journal:  Immunogenetics       Date:  2009-07-14       Impact factor: 2.846

3.  Transcriptome analysis of porcine PBMCs after in vitro stimulation by LPS or PMA/ionomycin using an expression array targeting the pig immune response.

Authors:  Yu Gao; Laurence Flori; Jérome Lecardonnel; Diane Esquerré; Zhi-Liang Hu; Angélique Teillaud; Gaëtan Lemonnier; Francois Lefèvre; Isabelle P Oswald; Claire Rogel-Gaillard
Journal:  BMC Genomics       Date:  2010-05-11       Impact factor: 3.969

4.  Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach.

Authors:  S D McCarthy; S M Waters; D A Kenny; M G Diskin; R Fitzpatrick; J Patton; D C Wathes; D G Morris
Journal:  Physiol Genomics       Date:  2010-08-17       Impact factor: 3.107

5.  Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors.

Authors:  M López-Cabrera; A G Santis; E Fernández-Ruiz; R Blacher; F Esch; P Sánchez-Mateos; F Sánchez-Madrid
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

6.  Genetic deletion of Mst1 alters T cell function and protects against autoimmunity.

Authors:  Konstantin V Salojin; Brian D Hamman; Wei Chun Chang; Kanchan G Jhaver; Amin Al-Shami; Jeannette Crisostomo; Carrie Wilkins; Ann Marie Digeorge-Foushee; Jason Allen; Nita Patel; Suma Gopinathan; Julia Zhou; Amr Nouraldeen; Theodore C Jessop; Jeffrey T Bagdanoff; David J Augeri; Robert Read; Peter Vogel; Jonathan Swaffield; Alan Wilson; Kenneth A Platt; Kenneth G Carson; Alan Main; Brian P Zambrowicz; Tamas Oravecz
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

7.  Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.

Authors:  Adéla Nacer; Alexandru Movila; Fabien Sohet; Natasha M Girgis; Uma Mahesh Gundra; P'ng Loke; Richard Daneman; Ute Frevert
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

8.  Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers.

Authors:  Benjamin B Policicchio; Cuiling Xu; Egidio Brocca-Cofano; Kevin D Raehtz; Tianyu He; Dongzhu Ma; Hui Li; Ranjit Sivanandham; George S Haret-Richter; Tammy Dunsmore; Anita Trichel; John W Mellors; Beatrice H Hahn; George M Shaw; Ruy M Ribeiro; Ivona Pandrea; Cristian Apetrei
Journal:  PLoS Pathog       Date:  2016-09-15       Impact factor: 6.823

9.  The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.

Authors:  Ndongala Michel Lubaki; Patrick Younan; Rodrigo I Santos; Michelle Meyer; Mathieu Iampietro; Richard A Koup; Alexander Bukreyev
Journal:  PLoS Pathog       Date:  2016-12-08       Impact factor: 6.823

10.  Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells.

Authors:  Ryo Nagaya; Masako Mizuno-Kamiya; Eiji Takayama; Harumi Kawaki; Ippei Onoe; Toshiichiro Tanabe; Kuniteru Nagahara; Nobuo Kondoh
Journal:  Exp Ther Med       Date:  2013-11-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.